Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: A phase 1 study

Lloyd Mayer*, William M. Pandak, Gil Y. Melmed, Stephen B. Hanauer, Kristine Johnson, Denise Payne, Herbert Faleck, Robert J. Hariri, Steven A. Fischkoff

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: A phase 1 study'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science